Davidson Kempner Capital Management’s Immunovant, Inc. Warrants expiring 12/18/2024 IMVTW Stock Holding History
Bought
Maintained
Sold
Davidson Kempner Capital Management's IMVTW Position: Q2 2020 in Review
Davidson Kempner Capital Management sold out of Immunovant, Inc. Warrants expiring 12/18/2024 (IMVTW) in Q2 2020, closing a stake of 474,400 shares — an estimated $1.07M sold.
Davidson Kempner Capital Management first reported a position in IMVTW in Q4 2019 and held it in 2 quarters. The position peaked at $1.07M in Q1 2020. 0 funds tracked by Wall St. Rank hold IMVTW as of Q2 2020.
- Davidson Kempner Capital Management reported no remaining Immunovant, Inc. Warrants expiring 12/18/2024 position as of Q2 2020 after selling out during the quarter.
- Davidson Kempner Capital Management sold 474,400 Immunovant, Inc. Warrants expiring 12/18/2024 shares in Q2 2020, an estimated $1.07M.
- Davidson Kempner Capital Management first reported a position in Immunovant, Inc. Warrants expiring 12/18/2024 in Q4 2019 and held it in 2 quarters.
- Davidson Kempner Capital Management's Immunovant, Inc. Warrants expiring 12/18/2024 position peaked at $1.07M in Q1 2020.
- 0 funds tracked by Wall St. Rank held Immunovant, Inc. Warrants expiring 12/18/2024 as of Q2 2020.
Based on Davidson Kempner Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.